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Abstract
Background—Dickkopf-related protein (DKK) 3 is a secreted protein that is involved in the 
regulation of cardiac remodeling and vascular smooth muscle cell differentiation, but little is 
known about its role in atherosclerosis. 
Methods—We tested the hypothesis that DKK3 is atheroprotective using both epidemiological 
and experimental approaches. Blood DKK3 levels were measured in the Bruneck Study in 2000 
(n=684) and then in 2005 (n=574). DKK3-deficient mice were crossed to ApoE-/- mice to 
evaluate atherosclerosis development and vessel injury-induced neointimal formation. 
Endothelial cell migration and the underlying mechanisms were studied using in vitro cell 
culture models.  
Results—In the prospective population-based Bruneck Study, the level of plasma DKK3 was 
inversely related to carotid artery intima-media thickness and five-year progression of carotid 
atherosclerosis, independently from standard risk factors for atherosclerosis. Experimentally, we 
analyzed the area of atherosclerotic lesions, femoral artery injury-induced re-endothelialization 
and neointima formation in both DKK3-/-/ApoE-/- and DKK3+/+/ApoE-/- mice. It was demonstrated 
that DKK3 deficiency accelerated atherosclerosis and delayed re-endothelialization with 
consequently exacerbated neointima formation. To explore the underlying mechanisms, we 
performed transwell and scratch migration assays using cultured human endothelial cells, which 
exhibited a significant induction in cell migration in response to DKK3 stimulation. This DKK3-
induced migration was associated with activation of ROR2 and DVL1, activated Rac1 GTPases 
and upregulated JNK and c-jun phosphorylation in endothelial cells. Knockdown of ROR2 
receptor using specific siRNA or transfection of a dominant negative form of Rac1 in endothelial 
cells markedly inhibited cell migration and downstream JNK and c-jun phosphorylation.  
Conclusions—This study provides the evidence for a role of DKK3 in the protection against 
atherosclerosis involving endothelial migration and repair, with great therapeutic potential 
implications against atherosclerosis.
Key Words: atherosclerosis; population studies; animal model cardiovascular disease; 
endothelial cell; DKK3
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Clinical Perspective
What is new?
x We found that plasma level of dickkopf-related protein 3 (DKK3), a member of the
dickkopf family is negatively correlated with atherosclerosis in human subjects.
x We demonstrated that DKK3 promotes re-endothelialization in murine models of
atherosclerosis and wire-induced femoral artery injury, thus revealing its atheroprotective
role.
x We explored the mechanism of DKK3-induced endothelial cell migration, i.e. via non-
canonical Wnt signaling pathway.
What are the clinical implications?
x The present finding of an inverse association between plasma DKK3 level and
atherosclerosis may provide a novel biomarker for endothelial integrity and repair.
x DKK3 exhibits  atheroprotective characteristics, which may bear clinical potential for
treatment of atherosclerosis.
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The dickkopf-related protein (DKK) family, composed of DKK1, 2, 3, 4 and Soggy, is a group 
of secreted glycoproteins, of which DKK3 is highly expressed in endothelium and muscles1-4.
DKK3 appears to have a decisive function in myogenic cell fate since it is also highly expressed 
in different skeletal muscle subtypes5. DKK3 has also been established as a potential tumor 
biomarker expressed in many cancer cell lines and an effective tumor suppressor in numerous 
human cancers6-8. It has been reported that DKK3 plays a role in promoting angiogenesis in 
different types of tumors9, 10. Recently, several studies have discovered that DKK3 prevented the 
progression of cardiac hypertrophy11, 12 and was also involved in vascular smooth muscle cell 
differentiation2, 4. However, the involvement of DKK3 in vascular diseases such as 
atherosclerosis remains unknown.  
Atherosclerosis is characterized by endothelial dysfunction, inflammation, progressive 
lipid deposition and vessel stiffness with potential complications such as myocardial infarction or 
stroke13,14. The endothelium, as a crude restrictive barrier of the vessel wall, can protect the 
vessel from inflammation. Once endothelial cells are impaired, they will become the initial 
sensors of a complex cascade of events15. Many studies have demonstrated that the underlying 
pathophysiology of atherosclerosis is initiated by endothelial dysfunction16, which is caused by 
physical or chemical offences such as hypertension17, shear stress of disturbed laminar flow18, 19,
reactive oxygen species in the circulation20, decreased nitric oxide bioactivity21, hyperlipidemia 
and hyperglycemia22. These factors can directly or indirectly induce endothelial 
dysfunction/death in arteries23 followed by cell regeneration in situ24. In this process, 
neighbouring endothelial cells have been proven to contribute to re-endothelialization by 
migration and proliferation25. In previous studies, vascular endothelial growth factor (VEGF) has 
been identified as a potent soluble factor for acceleration of re-endothelialization and prevention 
 by guest on July 21, 2017
http://circ.ahajournals.org/
D
ow
nloaded from
 
10.1161/CIRCULATIONAHA.117.027690
5 
of neointima formation26, 27. However, whether some novel soluble molecules are also playing a 
role in endothelial repair remains under investigation. In the present study, we take advantage of 
relevant human samples, transgenic animals and in vitro cell biology models to elucidate the 
potential impact of DKK3 in atherosclerosis. In humans, we observed an inverse correlation 
between blood DKK3 level and development of atherosclerosis. In addition, we utilized genetic 
knockout mouse models combined with ApoE-/- mouse to assess the effects of DKK3 on 
atherosclerosis, re-endothelialization and neointima formation after femoral artery injury. We 
found that DKK3 promoted re-endothelialization and inhibited lesion formation in 
DKK3+/+ApoE-/- mice. Our in vitro studies also revealed that DKK3 can induce endothelial cell 
migration via non-canonical Wnt signaling pathway.
Methods
An expanded Methods is available in the online-only Data Supplement.
Study Population
Population recruitment was performed as part of the prospective community-based Bruneck 
Study28, 29. The survey area was located in the north of Italy (Bolzano Province). Special features 
of the study design and protocol have been described previously in detail28-30 and are provided in 
the online-only Data Supplement. The current study focused on the evaluation in 2000 (n=684) 
and follow-up between 2000 and 2005. The appropriate ethics committees approved the study 
protocol and all study subjects gave their written informed consent before entering the study. 
Enzyme-Linked Immunosorbent Assay (ELISA) for Plasma DKK3
The levels of DKK3 in human plasma were detected using R&D DKK3 ELISA kit (R&D, 
DY1118). DKK1 levels were measured in serum with a commercial ELISA (Biomedica, Vienna, 
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Austria): Intra- and inter-assay CVs were low at 3% each and the lower detection limit was 1.6 
pmol/L.
Animals
All animal experiments were performed according to the protocols approved by the Institutional 
Committee for the Use and Care of Laboratory Animals. ApoE-/- mice were purchased from the 
Jackson Laboratory. DKK3-/- mice were generated as described previously31. Three genotypes of 
DKK3-/-, DKK3-/+ and DKK3+/+ mice were identified using PCR (primers:5-
GATAGCTTTCCGGGACACAC-3; 5-TCCATCAGCTCCTCCA CCTCT-3; 5-
TAAGTTGGGTAACGCCAGGGT-3). ApoE-/- mice were crossed with DKK3-/- mice in our 
laboratory, and heterozygous offsprings were mated to produce ApoE-/- mice lacking DKK3 
(DKK3-/-ApoE-/-). The genetic background of all mice used in the present study was C57BL/6. 
Creation of Chimeric Mice
The procedure used for creating chimeric mice was similar to previously described32. In brief, 
bone marrow transplantation was carried out on the DKK3+/+ mice and DKK3-/- mice separately. 
Bone marrow cells were obtained from the femurs and tibias of either DKK3+/+ or DKK3-/- mice
(donors) and injected (1x107cells in 0.2ml) into the tail veins of the 6-8 week old DKK3-/- mice 
or DKK3+/+ mice (recipients), which received lethal irradiation (950 Rads) before. The 
measurement of DKK3 level in peripheral blood was performed 3 weeks after bone marrow 
transplantation.   
Tissue Harvesting and Lesion Analysis 
Mice were anesthetized by intraperitoneal injection of pentobarbital atrium (50mg/kg b.w.). 
Blood was obtained from inferior vena cava for lipid analysis. The heart was harvested intact and 
stored immediately in liquid nitrogen and the whole length of the aorta was stored in formalin at 
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4°C. 8-Pm thick frozen sections were obtained from the heart and were stained with Oil Red O 
as described elsewhere33. Aortas were opened longitudinally and fixed on a silicon bed with 
stainless steel pins (Fine Science Tool, USA) with the intima exposed. Oil Red O staining was 
performed. Lesion areas were measured and quantified using a computer software AxioVision™ 
as described previously. 
Transwell Chemotaxis Assay 
Migration chemotaxis assay was performed by applying 24-well Boyden chambers with 8 μm 
pore size polycarbonate membranes (Corning) as described previously34. HUVECs were seeded 
onto the upper chamber at 1x105 cells in 0.1% FBS EBM-2 basal medium, while the bottom 
chamber contained either 0.1% FBS EBM-2 basal medium with indicated concentrations of 
recombinant human DKK3 or Adeno-DKK3-HA/Adeno-CMV null overexpressed CHO cells 
supernatant. 0.1% FBS EBM-2 basal medium served as negative control for the comparison with 
recombinant human DKK3. After incubation for 6 hours at 37°C, the cells remained on the upper 
side of the filters were removed by a cotton swab. The migrated cells on the underside of the 
membrane were fixed with 4% paraformaldehyde prior to staining with 0.1% crystal violet 
solution for 15 minutes. Data was expressed as the fold of migrated HUVECs compared to their 
corresponding controls. 
Statistical Analysis 
Population study 
The data were analyzed using the SPSS 24 software package. Levels of variables according to 
DKK3 tertile groups were presented as mean values ± SD or as medians with corresponding 25th 
and 75th percentiles (continuous variables), and percentages (dichotomous variables). 
Associations between DKK3 level (predictor variable) and vascular risk factors, life style and 
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demographic variables, IMT and atherosclerosis progression were assessed using linear and 
logistic regression analysis. Levels of C-reactive protein and triglycerides were loge-transformed 
to satisfy the assumption of normality and constant variance of the residuals. The multivariate 
models focusing on IMT or atherosclerosis progression included the following covariates: age 
(years), sex (female, male), smoking (cigarettes/day), hypertension, HDL and LDL cholesterol, 
triglycerides, hsCRP, creatinine, body mass index, wait-to-hip ratio, chronic infections, fasting 
glucose, and physical activity (sports score). A two-sided p value < 0.05 was considered 
significant.
In vivo and in vitro studies 
Data for in vivo and in vitro studies are presented as the mean ± standard error of the mean 
(S.E.M.) of at least three separate experiments. The analysis was performed using Graphpad 
Prism V.6 (GraphPad Software, San Diego CA) using t-test between two groups and analysis of 
variance (one-way ANOVA) followed by Dunnett’s multiple comparison test for more than two 
groups. A p value<0.05 was considered significant. 
Results
Plasma DKK3 Level is Negatively Correlated with Atherosclerosis in the Population-based 
Bruneck Study
The Bruneck study is a prospective survey on atherosclerosis and its risk factors, as well as 
protective mechanisms against it28, 29. Plasma was collected from a random sample of the general 
community. A total of 611 samples from the year 2000 and 554 samples from the year 2005 were 
analyzed for DKK3 concentrations using ELISA. DKK3 levels in both assessments were highly 
correlated indicating a low intra-individual variability of a five-year interval (Spearman’s rank 
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correlation coefficient r=0.500) (Supplement Figure 1). Population characteristics according to 
DKK3 tertile groups are depicted in Table 1. Age increased across DKK3 tertile groups 
(p<0.001). After adjustment for age and sex, several standard and emerging cardiovascular risk 
factors showed association with DKK3 level (creatinine, body mass index, waist-to-hip ratio, and 
fasting glucose) and all these associations were inverse (Table 1). Of note, common carotid 
artery intima-media thickness (CCA IMT), a surrogate marker of early vessel pathology, was 
reduced in the top DKK3 tertile group (p=0.008) (Figure 1A). There was also a gradual decrease 
in the risk of incident atherosclerosis (incident plaques, n=59 out of 259 subjects free of carotid 
atherosclerosis at baseline, Figure 1B) and carotid artery stenosis (advanced plaques, n=63 out of 
332 subjects with pre-existent carotid atherosclerosis, Figure 1C) across DKK3 tertile groups 
(p<0.05 each).  
We next calculated the odd ratios of incident atherosclerosis and stenosis for a 1-SD unit 
higher DKK3 level (logistic regression analysis, p=0.035 and 0.004, Model 1, Table S1) and 
confirmed the associations to be independent of a broad panel of established and putative 
vascular risk factors including those significantly related to DKK3 level in Table 1 (Model 2, 
Supplement Table 1). Similar findings were obtained with CCA-IMT (Supplement Table 1). 
Overall, there is strong evidence of an inverse association between DKK3 level and both early 
and advanced stages of atherosclerosis. To scrutinize the correlation between DKK3 and other 
circulating factors in the blood, G-CSF, MMP9, VEGF, SDF-1, sRANKL, osteoprotegerin and 
angiogenic cells levels were measured. SDF-1 was significantly related to DKK3 (p=0.021, 
adjusted for age and sex) (Supplement Table 2).  
Interestingly, the level of DKK1, another member of the Dickkopf family, showed a 
significant positive association with CCA-IMT (age- and sex-adjusted regression coefficient 
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[95% CI] for a 1-SD unit higher DKK1 level, 0.031 [0.008 to 0.054]). The inverse association 
between DKK3 and CCA-IMT was more pronounced in subjects with KLJKSPRO/LH
median) DKK1 level (age- and sex-adjusted regression coefficient [95% CI] for a 1-SD unit 
higher DKK3 level, -0.018 [-0.037 to 0.001]) than in those with low (<44.1 pmol/L) DKK1 level 
(age- and sex-adjusted regression coefficient [95% CI] for a 1-SD unit higher DKK3 level, -
0.011 [-0.027 to 0.004]) but this interactive effect between DKK1 and DKK3 did not reach 
statistical significance (Pinteraction=0.17).  
Deficiency of DKK3 Promotes Atherosclerosis in Mice
To investigate the role of DKK3 in the development of atherosclerosis, we crossed DKK3-
deficient mice35 with ApoE-/- animals to generate DKK3-/-ApoE-/- mice (Supplement Figure 2). As 
observed with the measurement of atherosclerotic lesions by en face staining (oil red O) of aortas 
(Figure 2C and Supplement Figure 3), cross-sectional analysis of aortic root samples in male 
mice fed a normal chow diet for 16 weeks revealed smaller lesion in DKK3+/+/ApoE-/- than in 
DKK3-/-/ApoE-/- mice (Figure 2A and 2B). Analysis by immunofluorescence showed a significant 
increase of Į60$VWDLQLQJLQOHVLRQVIURPDKK3+/+/ApoE-/- mice (Figure 2A and 2D) compared 
to DKK3-/-ApoE-/-, suggesting these smaller lesions were more stable and less advanced. 
Furthermore, a staining against CD68 marker revealed a reduction in the number of lesional 
macrophages in DKK3+/+/ApoE-/- mice (Figure 2A and 2D). All together, these data suggest that 
DKK3 could have a protective role against atherosclerosis in ApoE-/- mice.
DKK3 Deficiency Leads to Endothelial Dysfunction in ApoE-/- Mice
It is well established that endothelial cells play an essential role in the homeostasis of vascular 
wall36. To investigate the possible mechanism associated with the accelerated atherosclerosis in 
DKK3-/-/ApoE-/- mice, we first analyzed the integrity of the endothelium by injecting Evans blue 
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in DKK3-/-/ApoE-/- and DKK3+/+/ApoE-/- mice. The aortas harvested from DKK3-/-/ApoE-/- mice 
exhibited a larger blue area, indicating more endothelial damage (Figure 3A). Scanning electron 
microscopy analysis demonstrated apparent endothelium loss in the aortas from DKK3-/-/ApoE-/-
mice (Figure 3B). To further confirm the impaired endothelial integrity in DKK3-/-/ApoE-/- mice, 
immunofluorescence staining of endothelium marker eNOS was performed. A significant 
decrease in the number of eNOS-positive cells was observed in DKK3-/-/ApoE-/- mice (Figure 
3C). These data indicate DKK3-deficient mice display increased endothelium damage, 
suggesting a protective role of DKK3 on the endothelium in the context of atherosclerosis.  
DKK3 Deficiency Delays Re-endothelialization and Aggravates Neointima Formation in 
Wire-Injured Murine Femoral Arteries
To test the hypothesis that DKK3 is involved in post-injury endothelium recovery, we performed 
wire injury in femoral arteries of DKK3-/-/ApoE-/- and littermate DKK3+/+/ApoE-/- mice. Re-
endothelialization of the arteries was quantified one-week post injury by en face staining of 
endothelial marker eNOS. Endothelial cells were recovered by 80% after one week in 
DKK3+/+mice. In contrast, re-endothelialization in DKK3-/- mice was only about 50% recovery 
one-week post-injury (Supplement Figure 4). Subsequent neointimal hyperplasia was 
dramatically aggravated in DKK3-/- mice 2 and 3 weeks post-injury, as demonstrated by 
increased intima area and reduced lumen area (Figure 4A). To test whether the expression of 
DKK3 in hematopoietic cells contributed to this process, we performed bone marrow 
transplantation experiments. In the wild-type chimaera, DKK3 level in mice serum was 
significantly increased after 2 weeks despite transplantation with DKK3-/- bone marrow when 
compared to a non-transplanted wild-type mouse control, indicating that DKK3 is mostly 
released from non-bone marrow tissues (Supplement Figure 5). ApoE-/-/DKK3+/+ chimeric mice 
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transplanted with DKK3-/- bone marrow showed comparable neointimal hyperplasia to ApoE-/-
/DKK3+/+ mice with wild-type bone marrow 3 weeks after femoral artery wire injury (Figure 
4B), indicating that DKK3 expression in hematopoietic-derived cells does not contribute to 
protection from atherosclerosis and neointima formation post-injury.
Exogenous DKK3 Induces Endothelial Cell Migration 
To study whether DKK3 can directly stimulate endothelial cell migration in vitro, both transwell 
and scratch-wound healing migration assays were performed. Data showed that endothelial cell 
(HUVEC) migration was significantly induced by human recombinant DKK3 and peaked at 25 
ng/ml (Figure 5A, B). Similarly, mouse DKK3 induced mouse lung endothelial cell migration 
indicating a conserved mechanism (Supplement Figure 6A, B). To further investigate whether 
the glycosylated form of DKK3 contributes to endothelial cell migration, CHO cell lines, which 
do not express native DKK3, were transduced with human HA-tagged DKK3 adenovirus to 
produce the protein. Initially, qPCR and ELISA analysis confirmed DKK3 expression in both 
CHO cell lysates and their supernatant in a dose-dependent manner (Supplement Figure 6C, D). 
Additionally, Western blot analysis was performed to detect glycosylated DKK3 (65KD) in 
CHO cell supernatant and de-glycosylated DKK3 (50KD) in cell lysate (Supplement Figure 6E, 
F). Furthermore, the supernatant of DKK3-adenovirus induced CHO cells (ADV-DKK3-SN) 
was utilized in migration assays to confirm endothelial cell movement (Figure 5C, D). Together, 
these results suggested that glycosylated DKK3 present in ADV-DKK3-SN was responsible for 
the effects observed endothelial cell migration. To rule out the possibility that residual adenoviral 
particles present in ADV-DKK3-SN could lead to overexpression of DKK3 in endothelial cells 
and affect cells migration, a qPCR analysis was performed and showed that the increase of 
DKK3 expression in ADV-DKK3-SN treated-endothelial cells was negligible in comparison 
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with the induction of DKK3 expression in endothelial cells directly transduced with DKK3 
adenovirus (Supplement Figure 6G, H, I). Moreover, endothelial migration upon DKK3 protein 
stimulation was also confirmed by phospho-FAK and paxillin staining (Figure 5E, F). A murine 
subcutaneous Matrigel plug assay showed that DKK3 also induced endothelial cell migration in 
vivo (Supplement Figure 7). On the other hand, BrdU cell proliferation and Annexin V apoptosis 
assays on HUVECs incubated with the recombinant DKK3 protein or ADV-DKK3-SN revealed 
that DKK3 had no effect on cell proliferation or apoptosis, (Supplement Figure 8A, B). Taken 
together, the above results support the notion that exogenous DKK3 (especially glycosylated 
DKK3) significantly induce endothelial cell migration. 
DKK3 Induces Endothelial Cell Migration through the Wnt Pathways 
ȕ-catenin has been implicated in the regulation of several DKK3 functions through the :QWȕ-
catenin signaling pathway3. However, in DKK3 treated-endothelial FHOOVȕ-catenin was not 
activated as indicated by Western blot analysis or immunofluorescence staining (Supplement 
Figure 9A-C). Distinct from a role of the canonLFDO:QWȕ-catenin pathway in regulation of cell 
proliferation and development37, the non-canonical Wnt pathway is involved in cell polarity38
and convergent extension movements39. Recent studies have indicated that the tyrosine kinase 
receptor ROR2 plays an important role in non-canonical Wnt pathway to mediate cell 
migration40-42. To investigate whether DKK3 induces cell migration through WKHȕ-catenin-
independent non-canonical Wnt-PCP pathway, firstly, we performed co-immunoprecipitation
analysis which revealed the binding of DKK3 to ROR2 in endothelial cells after stimulation with
either recombinant DKK3 or DKK3-CHO SN (Figure 6A). This result implicates that 
transmembrane receptor ROR2 could be a potential binding site for DKK3. As previous studies 
have demonstrated, members of the Dishevelled family can mediate the Wnt-PCP signaling
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pathway following activation of ROR2. Hence, we further investigated Dvl1, 2, 3 gene 
expression levels, and found that only Dvl1 displayed a 5-fold reduction upon stimulation with 
DKK3 after 6 hours (Figure 6B). Further immunofluorescence staining of DVL1 revealed its
translocation from cytoplasm to the nucleus after DKK3 treatments for 6 hours (Figure 6C). 
To study the downstream signaling  pathways activated after the binding of DKK3 to 
ROR2, we measured the level of GTP-Rac1 and GTP-RhoA using pull-down assays. The level 
of GTP-Rac1 (Figure 6D) but not GTP-RhoA (Supplement Figure 10) was significantly up-
regulated by both recombinant human DKK3 or CHO supernatant, which indicated that Rac1 but 
not RhoA can be activated by DKK3. A time course Western blotting analysis showed 
phosphorylation of JNK and c-jun occurred as early as 5 minutes after treatment with DKK3 in 
endothelial cells (Figure 6E).  siRNA-mediated knockdown of ROR2 in DKK3 treated HUVECs 
(Figure 6F) not only significantly reduced downstream DVL1 protein level, JNK and  c-jun 
phosphorylation (Figure 6G) but also inhibited cell migration, therefore placing ROR2 at the top 
of the signaling cascade mediating DKK3-induced migration (Figure 6J). Successful transfection 
of plasmids coding for eGFP-labeled constitutive Rac1 mutants were shown by quantitative 
FACS analysis (Supplement Figure 10). Moreover, phosphorylation of JNK was markedly 
upregulated in response to DKK3 treatment in cells transfected with constitutively active Rac1, 
but not with constitutively negative mutant (Figure 6H). Importantly, migratory abilities of 
endothelial cells were enhanced in Rac1 constitutively activated cells in response to DKK3 
treatment (Figure 6).  Finally, migration of endothelial cells towards DKK3 stimulation was 
markedly reduced in the presence of SP 600125 (an inhibitor of the JNK) (Figure 6K). 
Therefore, these data indicate that DKK3 induces endothelial cell migration by activating Wnt-
PCP signaling pathway via Rac1/JNK but not RhoA.
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DKK3 Has no Effect on Leukocyte Migration. Leukocyte migration is critical for 
atherosclerosis development43, 44. As DKK3 is a potent attractant for endothelial cell migration, it 
would be crucial to know whether it can also induce leukocyte migration towards the lesion area 
during atherogenesis. To investigate this issue, the different cell populations contained in 
peritoneal cells from mice after DKK3 injection into the abdominal cavity were analyzed by 
FACS, and compared with the saline group (control). Unlike thioglycollate stimulation (positive 
control) in which cell number was markedly augmented, DKK3 treatment did not significantly 
increase the number of macrophages, T or B cells in total peritoneal cell population (Supplement 
Figure 11A, B). Furthermore, in vitro migration assay revealed that there was no significant 
difference of macrophage subpopulation migration towards various concentrations of mouse 
recombinant DKK3 (Supplement Figure 11C). Thus, we conclude that DKK3 does not induce 
leukocyte recruitment and migration in vitro and in vivo. 
Discussion
In previous reports, the role of DKK3 as a potential tumor suppressor has been well studied in 
several human cancers45, 46. In recent years, DKK3 was found to act as a potent protector of 
cardiac hypertrophy via Wnt signaling pathway11, 12, 47, and has been associated with stem cell 
differentiation into vascular smooth muscle cells2, 4. In the present study, we found that plasma 
DKK3 level was inversely and independently associated with CCA-IMT and incident carotid 
atherosclerosis and stenosis over a five-year follow-up suggesting that DKK3 confers protection 
against both early and advanced stages of atherogenesis.  
DKK3, as a secretory glycoprotein, can be released from a variety of tissues in mouse 
under physiological conditions, which explains the ubiquitous expression of DKK3 in vivo48. In 
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our study, we created chimeric mice models to further investigate which source of circulating
DKK3 takes part in the protection from atherosclerosis and neointima formation. In the DKK3-/-
chimeric mouse with wild-type bone marrow model, the DKK3 level in serum was barely
increased despite transplantation with wild-type bone marrow, indicating that DKK3 is mostly 
released from non-hematopoietic cells. Interestingly, the wild-type chimeric mice with DKK3-/-
bone marrow, exhibited even higher level of DKK3, implying that the bone marrow
transplantation procedure may induce even more non-hematopoietic cell release of DKK3 into
circulation. Given the evidence that endothelial cells express DKK3, the endothelium could be a
source of circulating DKK3. When endothelial cells are damaged or dysfunctional, their ability
to release DKK3 might also be decreased. Our findings support the notion that the lower levels
of DKK3 which were found in the blood of patients with atherosclerosis, could be explained by
lower DKK3 release due to endothelial dysfunction. While the specific cellular and molecular
mechanisms of DKK3 release remain unknown, further studies would be needed to clarify how
DKK3 is released into the blood.
After being released into the blood, DKK3 may exert its effect on endothelial cells and
subsequently the development of atherosclerosis. The endothelium is an indispensable barrier
inside the vessel wall and its integrity has been viewed as a determinant in atherogenesis,
especially in the early stages49, 50. As a progressive chronic disease, once initiated by risk factors, 
atherosclerosis provokes a cascade of pathophysiological responses51, including post-angioplasty
neointima formation and restenosis52. In our study, different experimental models have
confirmed that the endothelium was apparently dysfunctional or damaged in aortas of mice with 
DKK3 deficiency, suggesting that DKK3 plays a protective role in endothelial integrity. In
DKK3+/+/ApoE-/- mice the atherosclerotic lesion area was smaller compared with DKK3-/-/ApoE-/-
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mice. In the femoral artery wire injury model, DKK3 displayed not only properties of
protection of endothelium integrity by accelerating the re-endothelialization at the early stage, but
also of reduction of neointima formation at the late phase. The data derived from experimental
models provide the direct evidence that DKK3 could act as a chemokine-like protein in 
endothelial migration and thus be protective of atherosclerosis.
In the early stage of atherogenesis, endothelial regeneration is a critical protective
mechanism to repair damaged cells and to prevent the progression of atherosclerosis53, 54. As
mentioned above, an inverse correlation between blood DKK3 level and atherosclerosis in
humans and a reduction of post-injury arterial re-endothelialization in DKK3-/- mouse model
have been observed. It is rational to investigate if the effect of DKK3 on endothelial cell 
migration could contribute to endothelial repair. In vitro migration assays showed that exogenous 
DKK3 significantly induced endothelial cell migration. It was reported that DKK3 is a secreted
glycoprotein with four potential N-glycosylation sites, and endogenous DKK3 will be
glycosylated prior to its release into the supernatant3, 48, 55. In our study, enhanced-endothelial 
migration was induced by secreted/released DKK3 produced by Adeno-DKK3-CHO cells. The 
glycosylated form of DKK3 protein could be detected in the supernatant, suggesting that 
glycosylated-DKK3 is the main actor on endothelial cell migration. DKK3-induced endothelial 
migration could play a part in atherogenesis, but other potential effects of DKK3 on the 
development of the disease are still unknown. Further studies would be needed to understand its 
roles in the pathogenesis of atherosclerosis. 
Previous studies described that DKK3 was expressed in various tumor endothelial cells9, 
10 and that overexpression of DKK3 did not affect proliferation and migration of endothelial 
colony-forming cell10. Similarly, our data also showed that DKK3 within the cell following
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Adeno-DKK3 transduction did not induce cell migration, indicating that DKK3 may need to 
interact with its receptor(s) on the cell surface to exert its effects on cell movements.  As Wnt 
signaling pathway inhibitors, DKK-family members DKK1, DKK2 and DKK4 were proved to 
antagonize FDQRQLFDO:QWȕ-catenin signaling via Frizzled family receptors and LRP5/LRP6 co-
receptors3, 56. It has been demonstrated that DKK1 and DKK2 have important functions in 
endothelial function57-59, including the role of DKK1 plays  in accelerating pro-inflammatory 
response and atherosclerosis59. In the present study, we found that DKK1 level in human blood 
showed a significant positive association with atherosclerosis independently of DKK3 levels. In 
vitro study of cultured endothelial cells pre-treated with DKK3 did induce changes in DKK1-
induced IL-6 and MCP-1 expression (Supplement Figure 12). Importantly, LRP5 or LRP6 
antagonist sclerostin and draxin did not inhibit DKK3-induced activation of noncanonical Wnt 
signaling pathway (Supplement Figure 13). Thus, it seems that DKK3 exerts its effect on 
endothelial functions related to atherosclerosis independently of other members of DKK family 
proteins. 
In contrast with the other DKK-family members, the specific receptor(s) and the relevant 
signaling pathway(s), with which DKK3 interacts remain controversial. Several studies have 
GHPRQVWUDWHGWKDW'..H[HUWHGLWVIXQFWLRQVWKURXJKFDQRQLFDO:QWȕ-catenin signaling
pathway via Kremen20 and LRP560. On the other hand, other studies found no evidence that 
DKK3 binds to LRP5/6 or Krm1/2 or inhibits the canonical Wnt signaling pathway61, 62. In 
comparison with the canonical Wnt pathway, which is mainly involved in cell proliferation and 
differentiation, the non-canonical Wnt-planar cell polarity pathway interferes with cell adhesion, 
motility, and polarity38, 63. In the present study, we found that neither ȕ-catenin expression nor its 
cellular location was changed in endothelial cells after DKK3 treatment. Instead, our data 
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revealed that DKK3 induced cell migration through activation of GTPase Rac1 but not RhoA 
and phosphorylation of JNK and c-jun. These results suggest that DKK3-induced cell migration 
is mediated via a ROR2/Dvl1/Rac1/JNK signaling pathway (Supplement Figure 14).
 In summary, in the current study, we have provided the first evidence that DKK3 
potentially confers protection against atherosclerosis in human subjects and established that 
DKK3 affects atherosclerosis progression and neointimal formation in mouse models by 
influencing re-endothelialization. Furthermore, we identified ROR2/Dvl1/Rac1/JNK as the 
potential signaling pathway which relays DKK3 signal in endothelial cells in vitro to induce cell 
migration. Taken together, the findings indicate that DKK3 could be an atheroprotective 
cytokine that might serve as a biomarker of endothelial integrity and repair and a potential 
therapeutic agent e.g. for improving both early stage reendothelialization and long-term outcome 
of patients post-angioplasty. While substantial knowledge on vascular risk factors has 
accumulated over the past years, insights into protective mechanisms are limited and require 
more extensive studies.
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Table 1. Levels of study characteristics according to DKK3 tertile groups in the Bruneck Study.
DKK3 DKK3 DKK3
Variable Tertile I 
(<65 ng/mL)
Tertile II 
(65-74 ng/ml)
Tertile III 
QJPO
P value* P value†
Age 61.8r8.6 66.7r10.1 70.0r10.0 <0.001
Male sex (%) 51.3 45.4 44.9 0.208
Systolic BP (mmHg) 137.0r17.5 141.6r20.6 140.5r18.3 0.062 0.503
Diastolic BP (mmHg) 83.9r7.8 84.0r8.2 83.8r8.9 0.911 0.781
Hypertension (%) 48.3 60.3 60.0 0.018 0.860
Urinary albumin (g/dl) 23.2r53.7 19.4r43.5 62.8r282.5 0.188 0.537
Creatinine (mg/dl) 0.85r0.12 0.88r0.16 0.92r0.29 0.001 0.004
Leukocyte count (109/L) 6.2r1.6 6.1r1.6 6.2r1.8 0.788 0.954
hsCRP (mg/L) 1.8 (0.9-3.8) 1.7 (0.8-3.9) 1.8 (0.9-4.6) 0.974 0.064
Fibrinogen (mg/dl) 288.9r56.2 287.9r62.3 294.1r62.7 0.392 0.058
Chronic infections (%) 14.1 24.2 31.8 0.001 0.537
Ferritin (ȝJ/ 124.5r155.1 115.3r137.0 113.4r110.0 0.415 0.422
LDL (mg/dl) 148.5r40.0 151.8r35.8 144.8r35.1 0.317 0.311
HDL (mg/dl) 57.3r17.0 56.4r14.5 57.6r14.4 0.868 0.759
Triglycerides (mg/dl) 130 (88-173) 121 (92-165) 117 (78-157) 0.023 0.055
Body mass index (kg/m2) 26.3r3.7 25.2r4.1 24.6r4.1 <0.001 <0.001
WHR (cm/cm) 0.92r0.1 0.92r0.1 0.91r0.1 0.043 0.003
Physical activity (sports score) 2.4r0.8 2.3r0.7 2.3r0.8 0.059 0.110
Fast glucose (mg/dl) 103.7r27.6 102.0r25.8 99.2r19.1 0.063 0.001
Hba1c (mmol/mol) 4.1r0.7 4.1r0.7 4.1r0.6 0.315 0.120
Diabetes mellitus (%) 11.9 13.8 11.8 0.799 0.073
+RPRF\VWHLQȝPRO/ 12.5r12.1 13.0r5.0 13.7r5.2 0.162 0.846
Smoking (%) 19.9 13.8 15.3 0.256 0.759
Smoking (cigarettes/day) 2.6r6.3 1.9r5.5 1.2r3.7 0.005 0.243
Alcohol consumption (g/day) 24.9r32.2 20.9r31.1 18.4r23.7 0.050 0.179
P values were derived from linear regression analyses (continuous variables) and logistic regression 
analyses (categorical variables) comparing levels of study characteristics (outcome) across DKK3 
tertile groups (predictor). Analyses were either unadjusted (*) or adjusted for age and sex (†).
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Figure Legends
Figure 1. Plasma DKK3 level is inversely correlated with atherosclerosis in the prospective 
population-based Bruneck Study. A, Age- and sex-adjusted mean common carotid artery 
intima-media thickness (CCA IMT) was grouped according to DKK3 tertile groups. Odd ratios 
of incident carotid atherosclerosis (early atherogenesis) (B) and incident carotid stenosis 
manifesting between 2000 and 2005 (advanced atherogenesis) (C) according to baseline (2000) 
DKK3 tertile groups. The bottom tertile group served as the reference category. Analyses were 
adjusted for age and sex.
Figure 2. Atherosclerotic lesions in DKK3-/-/ApoE-/- mice. Mice receiving normal chow diet 
were killed at 20 weeks old, and the heart and aorta were harvested. The aortic root was 
sectioned, and aortas were mounted, stained with oil Red O.  Lesional areas in the aortic sinus 
and the surface were measured and quantified as described in the Methods. The sections were 
immunostained with anti-Į-smooth actin and CD68 antibodies, respectively. Positive cells were 
quantified under the microscope. A, Representative pictures of aortic sinus sections stained for 
RLO5HG2Į-smooth actin to identify smooth muscle cells and CD68 to identify macrophages; 
Measurement of lesions size on aortic sinus sections (B), on en face stained-lesion areas (C; % of 
WRWDOVXUIDFHDUHDVDQGTXDQWLILFDWLRQRIĮ60$DQG&'SRVLWLYHFHOOVD; % of total cells). 
*Significant difference between DKK3-/-/ApoE-/- and DKK3+/+/ApoE-/- groups, p<0.05 (n=11). 
Figure 3. Increased endothelial damage in DKK3-/-/ApoE-/- mice. A, Evans blue dye leaking 
study. Ten-week-old DKK3-/-/ApoE-/- and DKK3+/+/ApoE-/- mice received an injection of 1% 
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Evans blue dye via the tail vein. Mice were sacrificed, and aortas harvested and washed. Blue 
areas, representing the damaged area on the surface of aortas were observed. B, Scanning 
electron microscopy analysis of aortic samples from DKK3-/-/ApoE-/- and DKK3+/+/ApoE-/- mice.
Arrows indicate the damaged cell. C, En face preparation of the vessel was stained for 
endothelial marker eNOS and visualized following incubation with secondary Cy3 conjugated 
antibody. Quantitative data analysis of the number of endothelial eNOS positive cells around the 
bifurcation (bi) areas are presented in the graph (n=6), *p<0.01, indicating significant difference 
between the two groups.  
Figure 4. Increased neointimal lesions in DKK3-/-/ApoE-/- mice after vessel injury. Femoral 
arteries were wire-injured, harvested at different times after surgery, and cross-sectioned for 
morphological analysis. A, Representative Hematoxylin and Eosin (HE) stained sections of 
femoral arteries from DKK3-/-/ApoE-/- and DKK3+/+/ApoE-/- mice (upper panel). Means ±SEM 
from 6 mice for each group of the neointimal area, neontima/media ratio and luminal area are 
presented (lower panel). *p<0.01, indicating a significant difference between the two groups. B,
Representative HE stained sections of femoral arteries from a chimeric mouse, which is 
DKK3+/+/ApoE-/- mouse receiving DKK3-/-/ApoE-/- or DKK3+/+/ApoE-/- bone marrow after 
irradiation 3 weeks after vessel injury. The graph shows means±SEM of lesion areas (n=6).  No 
significant difference was noted between the two groups. 
Figure 5. DKK3 can induce endothelial cell migration. Chemotaxis of human umbilical vein 
endothelial cells (HUVECs; 1×105 FHOOVZHOODFURVVȝPWUDQVZHOOVWRZDUGHLWKHUKXPDQ
recombinant DKK3 (A) or Adeno-DKK3-overexpressed CHO supernatant (C) was counted 6 
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hours after crystal violet staining. 0.1% FBS EBM-2 medium or Adeno-CMV null-
overexpressed CHO supernatant was used as controls respectively, n=5. Scale bars, 100μm. B, 
D. Scratch-wound assay was performed on HUVECs. The chemotaxis index of each 
quantification was defined by the average of 9 fields of view from each well and was presented 
as fold increase compared to the corresponding controls, n=5. All graphs are shown as 
mean±SEM, **p<0.01, ***p<0.001. Null-CHO SN, Adeno-null overexpressed CHO 
supernatant; DKK3-CHO SN, Adeno-DKK3 overexpressed CHO supernatant; Scale bars, 
100μm. E, F. HUVECs were treated with human recombinant DKK3 for indicated time points 
before immunofluorescence staining of phosphorylated FAK and paxillin. ctrl, control; p-FAK, 
phosphorylated FAK. Scale bars, 50μm. 
Figure 6. DKK3 induces endothelial cell migration via ROR2/Dvl1/Rac1/JNK signaling
pathway. A. Western blot analysis showed the binding of ROR2 and DKK3 after 
immunoprecipitation of either DKK3 or HA-binding protein in HUVECs stimulated with DKK3 
or DKK3-CHO SN. B. The real-time quantitative PCR showed the fold changes in mRNA levels 
of DVL1, 2, 3 after DKK3 treatment. C.  Immunofluorescence staining showed the translocation 
of ROR2 and DVL1 in the nucleus after DKK3 treatments. D. Pull-down assays were performed 
on HUVECs treated with DKK3 from 1 to 30 minutes to analyze GTP-Rac1 activation. E.
Western blot analysis was performed on DKK3-treated HUVECs for the detection of JNK and c-
jun phosphorylation and their total expression. F. The gene and protein levels of ROR2 were 
analyzed by qPCR and FACS after knockdown by ROR2 siRNA. Western blotting showed the 
levels of ROR2, DVL1 proteins and JNK, c-jun phosphorylation in HUVECs after either control 
siRNA or ROR2 siRNA transfection (G), or phosphorylated JNK and c-jun levels in HUVECs 
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after transfection of constitutive mutants of Rac1 (H). Transwell assay was performed on 
HUVECs that were either transfected with constitutive mutants of Rac1 (I) or control, ROR2 
siRNA (J) before migration toward DKK3, 6 hours with either crystal violet staining or direct 
fluorescence observation of plasmid-transfected cells. K. Transwell assay was performed on 
HUVECs which migrated towards DKK3 in the presence of JNK inhibitor (SP600125) for 6 
hours. All the blots shown are representative of 3 separate experiments. All graphs are shown as 
mean±SEM, n=3, *p<0.05, **p<0.01, ***p<0.001.  DMSO, dimethyl sulfoxide; p-JNK, 
phosphorylated JNK; t-JNK, total JNK; p-c-jun, phosphorylated c-jun; t-JNK, total c-jun; act, 
constitutively active mutant; wt, constitutively wt mutant; neg, constitutively negative mutant. 
Scale bars, 100μm.
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SUPPLEMENTAL MATERIAL           Yu et al. 
Expanded Methods 
Study Population. Population recruitment was performed as part of the 
prospective community-based Bruneck Study1, 2. The survey area was located 
in the north of Italy (Bolzano Province). Special features of the study design 
and protocol have been described previously in detail1-3. At the study baseline 
in 1990, we recruited an age- and sex-stratified random sample from all 
inhabitants of Bruneck aged 40-79 years (125 women and 125 men each from 
the 5th to 8th decades of age, overall n=1000). A total of 919 subjects 
participated and had complete data assessment. Follow-up examinations were 
performed every five years with participation rates among survivors excceding 
90%: n=826 in 1995, n=684 in 2000, and n=574 in 2005. The current study 
utilized data and blood samples collected in the 2000 and 2005 examinations. 
The appropriate ethics committees approved the study protocol and all study 
subjects gave their written informed consent before entering the study. 
 
Clinical Examination and Laboratory Methods. Body mass index was 
calculated as weight divided by height squared (kg/m2). Diabetes was 
diagnosed according to American Diabetes Association (ADA) criteria. 
Hypertension was defined as blood pressure ≥140/90 mm Hg (mean of three 
independent measurements obtained with a standard mercury 
sphygmomanometer after at least ten minutes of rest) or the use of 
anti-hypertensive drugs1-5. All other parameters were assessed by standard 
procedures as detailed prreviously1-5. Blood samples were collected from 
antecubital vein after subjects had fasted and abstained from smoking for ≥12 
hours. Blood was collected in EDTA tubes and processed within 3 hours of 
collection. The APC-CFU assay and the APC culture assay were then 
performed promptly. Plasma was aliquoted and frozen for ELISA and other 
future use.  
Enzyme-Linked Immunosorbent Assay (ELISA) for Plasma Soluble 
Molecules Measurements. The levels of DKK3 in human plasma were 
detected using R&D DKK3 ELISA kit (R&D, DY1118). The capture antibody 
was diluted to a working concentration without carrier protein. A 96-well ELISA 
microplate (R&D, DY990) was immediately coated with 100µl of capture 
antibody, sealed (sealer, R&D, DY992), and incubated overnight at 4 oC. The 
next day the solution was removed and the wells were washed 3 times with 
wash buffer (provided in the kit). Each well was then blocked with 300µl of 
blocking reagent (provided in the kit) and maintained at room temperature for 
at least 1 hour. The wells were washed with wash buffer 3 times. 100µl of 
samples (diluted 1:10-1:100) or standards were added. The plate was covered 
with an adhesive strip and incubated at room temperature for 2 hours. Each 
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well was washed 3 times with wash buffer. 100µl of detection antibody was 
added and the plate was covered again with an adhesive sealer and incubated 
at room temperature for 1 hour and then removed. 100µl of streptavidin-HRP 
(provided in the kit) was added per well followed by 3 washes with wash buffer 
and incubation at room temperature for 20 minutes (avoiding direct exposure 
to light). 100µl of substrate solution (provided in the kit) consisting of equal 
volumes of color reagent A (H2O2) and color reagent B 
(Tetramethylbenzidine) was added per well and incubated at room 
temperature for another 15-25 minutes. The reaction was stopped by adding in 
50µl stop solution (2N sulphuric acid). The optical density of each well was 
determined immediately using a Tecan microplate reader set to 450 nm. The 
standard curve was created by plotting the concentration for each standard on 
the y-axis against the mean absorbance for each standard on the x-axis and 
drawing a best-fit curve through the points on the graph. The DKK3 
concentration was calculated according to the standard curve. DKK1 levels 
were measured in serum with a commercial ELISA (Biomedica, Vienna, 
Austria): Intra- and inter-assay CVs were low at 3% each and the lower 
detection limit was 1.6 pmol/L. 
The levels of plasma G-CSF, SDF1-α, VEGF and MMP-9 were also 
determined by using corresponding ELISA kits (Quantikine, R&D Systems, 
UK). All ELISA tests were carried out at room temperature on freshly thawed 
plasma samples. The concentrations of all cytokines were determined by 
comparison with a standard curve, following manufacturer’s instruction. Other 
laboratory parameters were all examined by standard methods. 
 
Angiogenic Promoting Cell (APC) Colony Forming Unit Assay 
(APC-CFU) and APC Culture Assay (APC number). Angiogenic promoting 
cell (APC) number and APC-CFU were assessed in 571 and 542 participants. 
Subjects with and without APCs number and APC-CFU did not differ in age, 
sex and expression of cardiovascular risk factors. Venous blood samples were 
collected as described above and the APC-CFU assay performed as 
described previously6-8. Briefly, peripheral blood mononuclear cells were 
isolated by density gradient centrifugation over lymphoprep (Axis-Shield, Oslo, 
Norway) at 800 G for 20 minutes. Peripheral blood mononuclear cells were 
resuspended in APC culture medium (M199 with 20%FCS and antibiotics) and 
then plated on fibronectin-coated 6-well plates at a concentration of 5 million 
cells per well. This step was designed to remove mature circulating endothelial 
cells which are rapidly adherent to fibronectin. Following culture for 48 hours, 
non-adherent cells were then aspirated, counted and, plated on 
fibronectin-coated 24-well plates at a concentration of 1 million cells per well. 
On day 5 of the assay, the medium was changed and on day 7 the endothelial 
colonies were counted manually. Strict guidelines were followed to ensure 
consistent counting of APC colonies. Two senior investigators who were 
blinded to the subjects’ clinical status counted colonies. Reproducibility was 
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assessed over 50 samples comparing colony counts by the two individuals. 
The coefficient of variance was <10% in each case. The APCs in a minimum of 
two wells were counted and the average was then recorded. Reproducibility 
was assessed over 50 samples by comparing the APC numbers from the two 
individuals. The coefficient of variance was <10% in each case. 
 
Scanning Protocol and Definition of Ultrasound End Points. The 
ultrasound protocol involves the scanning of the internal (bulbous and distal 
segments) and common carotid arteries (proximal and distal segments) of 
either side with a 10-MHz imaging probe3, 9. Atherosclerotic lesions were 
defined according to two ultrasound criteria: (1) wall surface (protrusion or 
roughness of the arterial boundary) and (2) wall texture (echogenicity). The 
maximum axial diameter of plaques (in millimeters) was assessed on the near 
and far walls at each of the eight vessel segments. for the follow-up between 
2000 and 2005 two stages of atherosclerosis development/progression were 
differentiated: (1) early atherogenesis was defined as the occurrence of new 
plaques in previously normal vessel segments, and (2) advanced 
atherogenesis (incident stenosis) was assumed whenever the relative 
increase in the maximum plaque diameter exceeded twice the measurement 
error for the method and a lumen narrowing > 40% (diameter stenosis) was 
achieved. The two progression categories were highly reproducible [kappa 
coefficients > 0.8 (n=100)]. Further details on imaging procedures and 
measurement errors have been published elsewhere3, 9, 10. The intima-media 
thickness (IMT) was quantified at the far wall of plaque-free sections of the 
common carotid arteries as the distance between the lumen-intima and 
media-adventitia interface (intra-observer coefficient of variation, 7.9 percent 
(n=100))3, 9.  
 
Animals. All animal experiments were performed according to the protocols 
approved by the Institutional Committee for the Use and Care of Laboratory 
Animals. ApoE-/- mice were purchased from the Jackson Laboratory. For 
ApoE-/- mice genotyping, the following primers were employed: oIMR180 
(5’-GCC TAG CCG AGG GAG AGC CG-3’), oIMR181 (5’-TGT GAC TTG GGA 
GCT CTG CAG C-3’), and oIMR182 (5’-GCC GCC CCG ACT GCA TCT-3’). 
DKK3-/- mice were generated as described previously11. Three genotypes of 
DKK3-/-, DKK3-/+ and DKK3+/+ mice were identified using PCR 
(primers:5-GATAGCTTTCCGGGACACAC-3; 5-TCCATCAGCTCCTCCA 
CCTCT-3; 5-TAAGTTGGGTAACGCCAGGGT-3). ApoE-/- mice were crossed 
with DKK3-/- mice in our laboratory, and heterozygous offspring were mated to 
produce ApoE-/- mice lacking DKK3 (DKK3-/-ApoE-/-). The mice were 
maintained on a light/dark (12/12 h) cycle at 22°C and received food and water 
ad libitum. The genetic background of all mice used in the present study was 
C57BL/6. 
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Creation of Chimeric Mice. The procedure used for creating chimeric mice 
was similar to previously described12. In brief, bone marrow transplantation was 
carried out on the DKK3+/+ mice and DKK3-/- mice separately. Bone marrow 
cells were obtained from the femurs and tibias of either DKK3+/+ or DKK3-/- 
mice (donors) and injected (1x107cells in 0.2ml) into the tail veins of the 6-8 
week old DKK3-/- mice or DKK3+/+ mice (recipients), which received lethal 
irradiation (950 Rads) before. The measurement of DKK3 level in peripheral 
blood was performed 3 weeks after bone marrow transplantation.   
 
Tissue Harvesting and Lesion Analysis. Mice were anesthetized by 
intraperitoneal injection of pentobarbital atrium (50mg/kg b.w.). Blood was 
obtained from inferior vena cava for lipid analysis. The heart was harvested 
intact and stored immediately in liquid nitrogen and the whole length of the 
aorta was stored in formalin at 4°C. 8-µm thick frozen sections were obtained 
from the heart and were stained with Oil Red O as described elsewhere13. 
Aortas were opened longitudinally and fixed on a silicon bed with stainless 
steel pins (Fine Science Tool, USA) with the intima exposed. Oil Red O 
staining was performed. Lesion areas were measured and quantified using a 
computer software AxioVision™ as described previously. 
 
Lipid Measurement. Blood from the mice was collected, centrifuged and the 
serum was kept for analysis. Serum cholesterol and triglyceride were 
measured with the Infinity™ Kit (Sigma) for cholesterol and triglyceride 
respectively.  
   
Endothelial Damage Assays in vivo. Evans blue dye stains blue in the areas 
where endothelium is damaged or dysfunctional14. Mice received intravenous 
Evans blue dye injection, and their aortas harvested, opened and blue areas 
were measured using a computer software AxioVision™. For scanning electron 
microscope analysis, mice were killed, and the aortas were fixed in situ with 2% 
formaldehyde plus 2% glutaformaldehyde and harvested. Aortic samples were 
fixed and processed as described previously. The samples were observed 
using a scanning electron microscopy in our central facility laboratory. 
 
Mouse Femoral Artery Denudation Injury. The mice were anesthetized and 
the surgical procedure was similar to that described previously15, 16. Removal of 
the endothelium of the common femoral arteries was achieved by 3 passages 
of a 0.25 mm angioplasty guidewire (Advanced Cardiovascular Systems). After 
removal of the wire, the branch of the femoral artery was ligated, and the 
wound was closed.  
 
Morphometric Analysis and Quantification of Lesion Formation. The 
femoral arteries were harvested at different times after the operation. The 
specimens were fixed in 4% formaldehyde for H&E staining. Sections (5µm) 
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were collected at 100µm intervals (10 sections per fragment), mounted on 
slides, and stained with H&E for morphometric analysis. The procedure used 
for lesion quantification was similar to that described previously17. Briefly, using 
Axiovision software, the area of neointima in a given image was highlighted 
and quantified (mm2) automatically. 10 sections were analyzed per vessel 
sample. Meanwhile, the thickness of the neointima and media of the vessel 
was examined. Because native media thickness is variable (reflecting the 
diameter of the artery), neointima thickness was assessed in the ratio of intima 
to intima plus media thickness. Re-endothelialization was defined by 
endothelial coverage of the luminal surface and assessed by x400 microscopic 
examination. 
 
En Face Staining. The mice were sacrificed after 48 hours, their aortas were 
harvested, processed and fixed as described previously18 and probed for 1 
hour at room temperature with rat anti-mouse antibodies against eNOS (BD 
Biosciences; 1:20 dilution). The secondary antibody used was rabbit anti-rat 
conjugated with Cy3 (DAKO Corp; 1:50 dilution).  
 
In vivo Matrigel Plug Assay. DKK3 or BSA (50 µl, 100µg/ml) were mixed well 
with and 250 µl Matrigel on ice, and injected subcutaneously into the mice. 6 
injections were conducted for each group. The plugs were harvested 14 days 
later. Samples were fixed in liquid nitrogen, cryosections were prepared and 
immunofluorescence staining was then performed.  
 
Immunofluorescence Staining. Frozen or paraffin sections on HUVECs were 
fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100 
(Sigma) and blocked with 5% normal donkey serum (Dako) for 1 hour at room 
temperature. Incubation of tissue sections or cells with primary antibodies was 
performed at 4oC overnight, followed by incubation with secondary antibodies 
(Corresponding fluorescent-conjugated IgG antibodies were used as 
secondary antibodies (Invitrogen)) for 45 mins at 37oC. Then tissue sections or 
cells were counterstained with DAPI (Sigma) for 5 mins at room temperature 
and mounted in fluorescent mounting media (Dako). Images were acquired 
using an Olympus IX81 microscope and assessed using Volocity software 
(PerkinElmer) or a Leica SP5 confocal microscope and LAS AF lite software. 
Total positive cells were counted using images obtained from the microscope, 
and these images were also used for calculating the percentage of positive 
cells. 
 
Isolation and Culture of Cells. HUVEC. Human umbilical vein endothelial 
cells (HUVECs) were purchased from Lonza (C2519A pooled donor) and 
cultured in complete Endothelial Growth Medium, EGM-2 Bullet kit (Lonza, 
CC3162). The cells were placed in a gelatin-coated plastic flask, incubated at 
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37℃，5% CO2 and were passaged every other day at a 1 to 3 ratio. The 
experiments were carried on HUVECs of passage 2-5. 
 
MLEC. Mouse lung endothelial cells (MLEC) were isolated using 
collagenase/dispase digestion method as previously described. Briefly, 8-10 
days old pups of C57BL/6J mice were euthanized before excision of three lung 
lobes of each mouse aseptically. The tissue was minced finely followed by 
enzymatic digestion with collagenase/dispase for 45 minutes at 37°C on a 
rotator. A single cell suspension was obtained by triturating tissue clumps and 
passing through cell strain before collecting cell pellets by centrifugation at 
400g for 5 minutes. Then the cells were resuspended and sorted with 
anti-PECAM-1 immunomagnetic microbeads to obtain MLEC. According to the 
instruction of magnetic cell sorting kits (MACS) (Miltenyi Biotec, GmbH, 
Bergisch Gladbach, Germany), briefly, the cells were incubated with the 
PECAM-1-conjugated/coated microbeads at 4°C for 15 minutes and then 
sorted using MACS columns (Miltenyi Biotec).  The PECAM-1 positive cells 
were plated on a gelatin-coated T75 flask and changed EGM-2 medium 4 
hours later to remove non-adherent cells and platelets.  
 
Mouse Peritoneal Macrophages. The isolation of mouse peritoneal 
macrophages was described as in previous studies14. Briefly, C57BL/6J mice 
were received an intraperitoneal (IP) injection of either 0.9% saline, 3% 
thioglycollate medium (Sigma-Aldrich) or recombinant mouse DKK3 protein 
(Thermo Fisher Scientific) in each mouse (1µg/20g). After 3 days, all the mice 
in different groups were euthanized by cervical dislocation, and 10 ml of cold 
sterile 3% Fetal Bovine Serum (FBS) PBS was injected through the peritoneal 
wall into each mouse. After injection, the peritoneal fluid was then withdrawn 
and centrifuged at 200g for 10 minutes at 4°C. The supernatant was discarded 
and cell components were analyzed by FACs analysis. 
 
CHO-K1 Cells. Chinese hamster ovary, CHO-K1 cell line was purchased from 
ATCC (CCL-61), and cultured in Nutrient Mixture F-12 Ham medium (Sigma 
N4888) supplemented with 2mM Glutamine and 10% Fetal Bovine Serum 
(FBS). The cells were passaged every other day at a 1 to 6 ratio.  
 
FACS Analysis. Mouse peritoneal macrophages were blocked with 
CD16/CD32 (Mouse BD Fc Block™) (BD Biosciences) for 5 minutes on ice 
before addition of antibodies CD11b, CD3, B220 or their corresponding IgG 
control for 30 minutes on ice before analysis by FACS in order to test the 
populations of macrophage, T cell and B cell in isolated peritoneal 
macrophages after stimulation with saline, thioglycollate  or DKK3 
recombinant protein in different mice. Data analysis was carried out using 
FlowJo software. 
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Antibodies and Inhibitors. Primary antibodies were goat anti-DKK3 (R&D 
Systems, AF1118), rabbit anti-HA tag antibody (ab9110), rabbit 
anti-Phospho-SAPK/JNK (Thr183/Tyr185) (cell signaling 4668), rabbit 
anti-SAPK/JNK (cell signaling 9252), rabbit anti-Phospho-c-jun (Ser63/73) 
(SC16312-R),  rabbit anti-c-jun (sc-1694), rabbit anti-FAK (phosphor Y397) 
antibody (ab4803), rabbit anti-paxillin (ab32084) and rabbit anti-ROR2 
(ab92379), rabbit Anti-Dishevelled/Dvl1 antibody (ab106844), mouse anti-Rac1 
(Millipore 05-389), mouse anti-RhoA (Cytoskeleton ARH04), mouse 
anti-active-β-catenin (Millipore 05-665), rabbit anti-β-catenin (ab32572), mouse 
anti-α-tubulin (Sigma T9026). Conjugated flow cytometry antibodies FITC 
anti-CD11b antibody (101205), FITC rat IgG2b, κ Isotype ctrl antibody 
(400605), PE anti-CD3 antibody (100205), PE rat IgG2b, κ Isotype ctrl antibody 
(400607) and APC anti-CD45R/B220 antibody (103211), APC rat IgG2a, κ 
Isotype ctrl antibody (400511) were purchased from Biolegend. Secondary 
antibodies for immunostaining were anti-mouse Alexa Fluor 546, anti-rabbit 
Alexa Fluor 546 and anti-rat Alexa546 and were purchased from Invitrogen. 
Human DKK1 (5439-DR-010), Draxin (6148-DR-025) and SOST/Sclerostin 
(1406-ST-025) were purchased from R&D System. Cells were also 
counterstained with Alexa Fluor® 488 Phalloidin (Life technologies A12379) 
and 10µg/ml 4', 6-diamidino-2-phenylindole (DAPI). Secondary antibodies for 
Western Blotting were purchased from Dako. JNK inhibitor SP600125 
(C14H8N2O) was purchased from Calbiochem. 
 
Plasmids and Cell Transfection. pcDNA3-EGFP-Rac1-Q61L (plasmid 
12981), pcDNA3-EGFP-Rac1-T17N (plasmid 12982), 
pcDNA3-EGFP-RhoA-Q63L (plasmid 12968), pcDNA3-EGFP-RhoA-T19N 
(plasmid 12967) were purchased from Addgene.  HUVECs were transfected 
with above plasmids using Lipofectamine 3000 (Thermo Fisher) in Opti-MEMTM 
(Thermo Fisher) medium according to the manufacturer's instructions. After 
incubation at 37°C for 6 hours, the medium was changed to complete EGM-2 
medium and migration assays were performed on transfected HUVECs 24 
hours post transfection.  
 
Adenovirus and Cell Transfection. Human DKK3-HA adenovirus (Abm 
085672A) and Adeno CMV-null (Abm 000047A) were purchased from Abm and 
amplified in HEK293 cells as described previously1. The empty vector virus 
(Adeno CMV-null) was applied as a negative control in experiments.  For 
overexpression of DKK3 in either CHO cells supernatant or HUVECs, 70% 
confluent CHO cells or HUVECs were infected with Adeno-DKK3-HA or 
Adeno-CMV null at a multiplicity of infection (MOI) of 10 for 6 hours before 
replacement of fresh serum free F-12 basal medium. The supernatant from 
CHO cells was harvested 48 hours after transduction and in which DKK3 
concentration was determined by human DKK3 DuoSet ELISA kit (R&D 
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DY1118). The evaluations of DKK3 overexpression in HUVECs were 
performed 48-72 hours after transfection. 
 
BrdU Proliferation Assay. HUVECs were treated with/without human DKK3 
recombinant protein in 0.1% FBS EBM-2 medium or 
Adeno-DKK3-HA/Adeno-CMV null transfected CHO cells supernatant at 
indicated time points on a gelatine coated 96-well culture plate. The 
proliferation assay was performed using a Cell Proliferation ELISA, BrdU 
(colorimetric) (Roche). According to the manufacturer’s instructions, the BrdU 
labeling solution was incubated with cells for 2 hours at 37℃ prior to fixation of 
cells. Then the fixed cells were incubated with BrdU peroxidase-conjugated 
antibody for 90 minutes at room temperature followed by incubation of 
substrate solution and stop solution until the color development was sufficient 
to be detected. The absorbance was measured at 450nm with correction at 
690nm. The proliferation of HUVECs was expressed as the fold of mean values 
of absorbance compared to their corresponding controls.  
 
Annexin V Apoptosis Assay. Apoptosis assay was performed on HUVECs 
using FITC Annexin V Apoptosis Detection Kit (BD PharmingenTM ) after 
treatment with/without human DKK3 recombinant protein in 0.1% FBS EBM-2 
medium or Adeno-DKK3-HA/Adeno-CMV null transfected CHO cells 
supernatant at indicated time points. As directed by manufacture’s instruction, 
1x105 cells of each sample were incubated with FITC Annexin V and Propidium 
Iodide (PI) together for 15 minutes at room temperature protected from light. 
Unstained cells, cells stained with FITC Annexin V or PI only severed as 
controls. The apoptotic cells were identified by FACS immediately after 
staining.  
   
Transwell Chemotaxis Assay. Migration chemotaxis assay was performed by 
applying 24-well Boyden chambers with 8 µm pore size polycarbonate 
membranes (Corning) as described previously19. HUVECs were seeded onto 
the upper chamber at 1x105 cells in 0.1% FBS EBM-2 basal medium, while the 
bottom chamber contained either 0.1% FBS EBM-2 basal medium with 
indicated concentrations of recombinant human DKK3 or 
Adeno-DKK3-HA/Adeno-CMV null overexpressed CHO cells supernatant. 
0.1% FBS EBM-2 basal medium served as negative control for the comparison 
with recombinant human DKK3. After incubation for 6 hours at 37°C, the cells 
remained on the upper side of the filters were removed by a cotton swab. The 
migrated cells on the underside of the membrane were fixed with 4% 
paraformaldehyde prior to staining with 0.1% crystal violet solution for 15 
minutes. Data was expressed as the fold of migrated HUVECs compared to 
their corresponding controls.  
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Scratch-Wound Assay. In each well of a 24-well plate, a straight scratch was 
made by a pipette tip to stimulate a 'wound' through the middle of 100% 
confluent HUVECs monolayer. The cells were treated with 0.1% FBS EBM-2 
basal medium with/without indicated concentrations of recombinant human 
DKK3 or Adeno-DKK3-HA/Adeno-CMV null overexpressed CHO cells 
supernatant. After 6 hours incubation, the migration of HUVECs into the 
“wound” area was quantified as the mean number of the migrated cells.  
 
RT-PCR and Quantitative Real Time Polymerase Chain Reaction (qPCR). 
Total RNA was isolated from HUVECs using a QIAGEN RNeasy Mini kit 
according to the manufacturer’s instructions. 1 µg RNA was reverse 
transcribed into cDNA using QuantiTect® Reverse Transcription Kit (Qiagen) in 
a 20 µl reaction. Then the qPCR was performed using 20ng of cDNA per 
sample with a SYBR Green Master Mix in a 20 µl reaction. Ct values were 
measured using the Eppendorf Mastercycler ep Realplex and GAPDH was 
used as an endogenous control to normalize the amounts of RNA in each 
sample. The primer sets are: 
ROR2, Forward Primer 5’-GTGCGGTGGCTAAAGAATGAT-3’  
Reverse Primer 5’-ATTCGCAGTCGTGAACCATATT-3’ 
DVL1, Forward Primer 5’-GAGGGTGCTCACTCGGATG-3’  
Reverse Primer 5’-GTGCCTGTCTCGTTGTCCA-3’ 
DKK3, Forward 5’-AGGACACGCAGCACAAATTG-3’ 
Reverse 5’-CCAGTCTGGTTGTTGGTTATCTT-3’ 
IL-6, Forward 5′-TTG CCT TCT TGG GAC TGA TGC T-3′  
Reverse 5′-GTA TCT CTC TGA AGG ACT CTG G-3′ 
MCP-1, Forward 5’-AGTAGGCTGGAGAGCTACAA-3’ 
Reverse 5’-GTATGTCTGGACCCATTCCTTC-3’  
 
Western Blot Analysis. Harvested cells were lysed with RIPA lysis buffer 
(Thermo Fisher) plus cOmplete Protease Inhibitor Cocktail Tablets (Roche), 
PhosSTOP Phosphatase Inhibitor Cocktail Tablets (Roche)  and proteins 
were sequentially measured using DCTM Protein Assay (Bio-Rad). 40 µg of 
total protein lysate for each sample was loaded into each well of 4-12% 
Bis-Tris Protein gels (NuPAPE, Novex) before being transferred to an 
Immobilon®-FL transfer membrane (Millipore), followed by a standard western 
blotting procedure.  
 
Rac1, RhoA GTPase Activation Assay. The activation assay of GTP-bound 
Rac1 or GTP-bound RhoA were carried out according to the manufacturer’s 
instructions of Rac1 Pull-down Activation Assay Kit (Cytoskeleton) and RhoA 
Pull-down Activation Assay Kit (Cytoskeleton) respectively. Briefly, cells were 
stimulated with the indicated treatments then harvested within cell lysis buffer 
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supplemented with protease inhibitor cocktail (reagents all supplied by kits). 
Then Rac1 and RhoA activity were assessed using GST-tagged p21 binding 
domain (PBD) of PAK agarose beads or glutathione S transferase 
(GST)-tagged Rho-binding domain (RBD) of Rhotekin beads to pull-down 
GTP-Rac1 or GTP-RhoA from lysates separately. Aliquots were collected for 
total Rac1 or Cdc42 (input) and GTPγS (positive) and GDP (negative) control 
analysis. Samples were separated by 4–12% Bis-Tris gels, transferred to 
PVDF membranes, and blotted with Rac1 (Millipore, 05-389) or RhoA antibody 
(Cytoskeleton, ARH03). 
 
Statistical Analysis 
Population study. The data were analyzed using the SPSS 24 software 
package. Levels of variables according to DKK3 tertile groups were presented 
as mean values ± SD or as medians with corresponding 25th and 75th 
percentiles (continuous variables), and percentages (dichotomous variables). 
Associations between DKK3 level (predictor variable) and vascular risk factors, 
life style and demographic variables, IMT and atherosclerosis progression were 
assessed using linear and logistic regression analysis. Levels of variables with 
a markedly skewed distribution were loge-transformed to satisfy the assumption 
of normality and constant variance of the residuals. The multivariate models 
focusing on IMT or atherosclerosis progression included the following 
covariates: age (years), sex (female, male), smoking (cigarettes/day), 
hypertension, HDL and LDL cholesterol, triglycerides, hsCRP, creatinine, body 
mass index, wait-to-hip ratio, chronic infections, fasting glucose, and physical 
activity (sports score). A two-sided p value < 0.05 was considered significant. 
In vivo and in vitro studies. Data for in vivo and in vitro studies are presented 
as the mean ± standard error of the mean (S.E.M.) of at least three separate 
experiments. The analysis was performed using Graphpad Prism V.6 
(GraphPad Software, San Diego CA) using t-test between two groups and 
analysis of variance (one-way ANOVA) followed by Dunnett’s multiple 
comparison test for more than two groups. A p value<0.05 was considered 
significant.  
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Table S1. Association of DKK3 level with common 
carotid artery IMT and progression of carotid 
atherosclerosis.  
 
Incident atherosclerosis (2000 to 2005)     
  
        OR (95% CI) for a 1-SD         P value 
            higher DKK3 level 
  
Model 1   0.64 (0.42-0.97)  0.035 
 
Model 2   0.61 (0.39-0.95)  0.030    
  
 
Incident stenosis (2000 to 2005) 
  
        OR (95% CI) for a 1-SD         P value 
            higher DKK3 level 
  
Model 1   0.56 (0.38 to 0.83)  0.004 
 
Model 2   0.53 (0.35 to 0.82)  0.004    
  
 
Intima-media thickness IMT (mm) 
  
        Regression coefficient            P value 
                                              (95% CI) for a 1-SD unit  
                                                  higher DKK3 level   
  
Model 1      -0.014 (-0.027 to -0.002) 0.020 
 
Model 2       -0.012 (-0.024 to 0.001) 0.065    
  
ORs (odds ratios) were derived from logistic regression analysis of 
incident carotid atherosclerosis/stenosis on baseline (2000) DKK3 
levels, age and sex (Model 1) plus smoking (cigarettes/day), 
hypertension, HDL and LDL cholesterol, loge-transformed triglycerides, loge-transformed hsCRP, creatinine, body mass index, wait-to-hip ratio, chronic infections, fasting glucose and physical 
activity (sports score) (Model 2). The analysis on incident plaques 
focused on subjects free of carotid atherosclerosis in 2000 (n=259, 
incident plaques were observed in 59 individuals) and that on incident 
stenosis considered subjects with pre-existent carotid atherosclerosis 
only (n=332, incident stenosis was observed in 63 individuals). 
Regression coefficients were derived from linear regression models 
focusing on the common carotid artery intima-media thickness (IMT) 
measured in 2000 (same adjustment). 
The SD of DKK3 level is 19.11.   
  
          
 
 
 
 
Table S2. Levels of cytokines and APCs according to DKK3 tertile groups in the Bruneck Study. 
 
 DKK3 DKK3 DKK3   
Variable Tertile I  
(<65 ng/mL) 
Tertile II  
(65-74 ng/ml) 
Tertile III  
(≥75 ng/ml) 
P value*  P value† 
      
APC-CFUs  
(per 106 PBMNC)  
104 (0-222) 83 (1-294) 79 (0-314) 0.900 0.633 
APC number  
(per 106 PBMNC)  
611 (285-998) 524 (192-1104) 489 (162-1086) 0.148 0.485 
G-CSF (pg/ml)  8.5 (4.1-15.7) 10.1 (4.3-16.6) 10.0 (4.3-18.3) 0.120 0.511 
MMP9 (ng/ml)  59.0 (34.8-110.0) 67.9 (38.9-102.0) 67.0 (31.7-121.7) 0.530 0.411 
VEGF (pg/ml)  62.8 (27.3-149.2) 91.9 (32.0-186.5) 66.3 (28.0-147.5) 0.731 0.839 
SDF-1 (pg/ml)  2465 (2247-2703) 2467 (2220-2804) 2693 (2362-3010) <0.001 0.021 
sRANKL (pmol/l) 1.2±0.9 1.3±1.2 1.2±1.1 0.701 0.356 
Osteoprotegerin (pmol/L) 3.7±1.0 4.1±1.8 4.4±1.5 <0.001 0.130 
P values were derived from linear regression analyses (continuous variables) and logistic 
regression analyses (categorical variables) comparing levels of study characteristics (outcome) 
across DKK3 tertile groups (predictor). Analyses were either unadjusted (*) or adjusted for age 
and sex (†). 
Angiogenic promoting cell (APC) number and colony forming units (APC-CFUs) were 
available in 477 and 451 individuals, respectively. Cytokines levels were available as follows: 
granulocyte colony-stimulating factor (G-CSF) n=218, metalloproteinase 9 (MMP9) n=468, 
vascular endothelial growth factor (VEGF) n=311, and stromal cell-derived factor 1 (SDF-1) 
n=477. 
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Figure	S1.	DKK3	levels	of	each	human	subject	in	year	2000	and	2005.	Sca%erplot	
of	DKK3	levels	measured	in	2000	and	2005	in	the	same	individuals	with	regression	
line	 and	 95%	 CI.	 The	 open	 circles	 on	 the	 upper	 border	 of	 the	 ﬁgure	 indicate	
individuals	with	DKK3	levels	higher	than	the	range	of	the	y-axis.		
r,	Spearman’s	rank	correlaKon	coeﬃcient.		
Figure S2                                                   Yu et al. 
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Figure	 S2.	 CharacterizaEon	 of	DKK3-/-/ApoE-/-	 mice.	 	A)	 Phenotyping	 of	DKK3	 and	ApoE	
double	knockout	mice	as	idenKﬁed	by	RT-PCR.	B)	ELISA	measurement	of	serum	DKK3	levels	
in	DKK3	and	ApoE	double	knockout	mice.	Note	that	DKK3	is	almost	undetectable	in	DKK3-/-	
ApoE-/-	mice.	C)	Serum	total	cholesterol	of	DKK3-/-/ApoE-/-	and	DKK3+/+/ApoE-/-	mice	with	20	
weeks	of	age	was	measured	with	a	kit.		
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DKK3+/+/ApoE-/- 
Figure	S3.	AtheroscleroEc	lesions	in	DKK3-/-/ApoE-/-	mice.	Mice	receiving	normal	chow	diet	were	
killed	at	20	weeks,	and	aortas	were	harvested,	opended,	mounted	and	stained	with	oil	Red	O.		
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Figure S4     Yu et al. 
Figure	S4.	Delayed	reendothelializaEon	in	injured	vessels	in	DKK3-/-
ApoE-/-	 mice.	 To	 establish	 reendothelializaKon	 model,	 femoral	
arteries	of	mice	were	injured.	En	face	preparaKon	of	the	vessel	was	
stained	for	endothelial	marker	eNOS	1	week	aZer	wire	injury.	Do%ed	
lines	 in	 images	 indicate	 the	 middle	 of	 the	 injured	 vessel,	 and	 the	
arrows	 indicate	 the	direcKon	of	cell	migraKon.	QuanKtaKve	data	of	
endothelial	 migraKon	 were	 presented	 in	 graphic	 data	 (n=6),	
**p<0.01,	signiﬁcant	diﬀerence	between	two	groups.	
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  Figure S5                                                                                 Yu et al. 
Figure	 S5.	 The	 source	 of	 DKK3	 in	 vivo.	 A.	 Using	
chimeric	 mice	 model,	 2	 weeks	 aZer	 bone	 marrow	
transplantaKon,	 the	 level	of	DKK3	 in	peripheral	blood	
was	measured	using	a	murine	DKK3	QuanKkine	ELISA	
kit.	 	 The	 quanKﬁcaKon	 in	 the	 graph	 shown	 mean	 ±	
SEM,	n=5/group.	 **p<0.01.	Wild-type	 (WT)	 to	DKK3-/-	
bone	 marrow	 transplantaKon，wild	 type	 mice	 with	
DKK3-/-	 bone	 marrow.	 DKK3-/-	 WT	 bone	 marrow	
transplantaKon,	 DKK3-/-	 mice	 with	 wild-type	 bone	
marrow.		
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Figure	S6.	Exogenous	DKK3	 induces	endothelial	 cell	migra9on.	 	 (A)	Transwell	assay	
was	performed	on	mouse	 lung	endothelial	cells	 (MLEC)	 that	migrated	toward	serum	
free	media	 containing	 indicated	 concentra=ons	 of	murine	 recombinant	 DKK3.	 Scale	
bars,	100µm.		(B)	The	quan=ﬁca=on	of	MLEC	migra=on	is	shown	as	mean	±	SEM,	n=3.	
*p<0.05.	**p<0.01.	qPCR	(C)	and	ELISA	(D)	analysis	were	performed	on	Adeno-DKK3-
transfected	CHO	cell	lysate	or	supernatant,	respec=vely,	to	analyze	mRNA	and	protein	
levels	 of	 DKK3	 aXer	 overexpression	 with	 human	 DKK3	 adenovirus	 in	 CHO	 cell.	
Signiﬁcant	 diﬀerence	 from	 the	 controls	 (n=3),	 ***p<0.001.	 Glycosyla=on	 or	 de-
glycosyla=on	of	DKK3	were	detected	by	both	an=-human	DKK3	an=body	and	an=-HA	
an=body	 in	 either	 supernatant	 (E)	 or	CHO	cell	 lysate	 (F)	 using	Western	blo]ng.	 (G)	
qPCR	 analyzed	 for	 DKK3	 gene	 expression	 in	 HUVECs	 treated	 with	 Adeno-DKK3-
transfected	CHO	supernatant	at	indicated	=me	points.	Signiﬁcant	diﬀerence	from	the	
controls	 (n=3),	 ***p<0.001.	 (H)	 Quan=ﬁca=on	 of	 DKK3	 gene	 expression	 in	 HUVECs	
aXer	Adeno-DKK3	 transfec=on	 for	 48	hours.	 Signiﬁcant	diﬀerence	 from	 the	 controls	
(n=3),	***p<0.001.	I.	Transwell	assay	was	performed	to	analyze	the	random	migratory	
ability	 of	 HUVECs	 which	 transfected	 with	 either	 Null	 or	 DKK3	 adenovirus.	 ns,	 not	
signiﬁcance.		
0	
100	
200	
300	
400	
500	
Ce
ll	
N
um
be
r/
ﬁe
ld
	
BSA DKK3 
*	
Figure S7      Yu et al. 
Figure	 S7.	 DKK3	 enhanced	 endothelial	 migra9on	 in	 Matrigel	 plug	 assay.	
DKK3	 or	 BSA	 (100mg/ml)	 was	 mixed	 	 with	 Matrigel	 and	 injected	
subcutaneously	 into	 mice.	 Two	 weeks	 aXer	 injec=on,	 Matrigel	 plugs	 were	
harvested	 and	 stained	 for	 HE	 (upper	 panel).	 Cell	 numbers	 within	 the	 plug	
were	enumerated.	Quan=ﬁca=on	data	are	means	±	SEM	of	two	groups	(n=3),	
*p<0.05.	 Frozen	 sec=ons	 were	 stained	 with	 EC	 speciﬁc	 marker	 eNOS	
demonstra=ng	 that	 DKK3	 plug	 displayed	 well-formed	 endothelial	 structures	
and	increased	cell	number	compared	to	the	BAS	control.		
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Figure	S8.	DKK3	has	no	eﬀect	on	HUVEC	proliferaEon	and	apoptosis.	(A)	ProliferaKon	of	
HUVECs	with	treatments	of	either	human	recombinant	DKK3	or	Adeno-DKK3-transfected	
CHO	 supernatant	 at	 indicated	 Kmes	 was	 evaluated	 by	 BrdU	 incorporaKon	 assay.	 ctrl,	
control,	serum	free	medium,	served	as	negaKve	control	of	 	human	recombinant	DKK3;	
Rmpr,	recombinant	DKK3	protein;	Null,	Adeno-Null-transfected	CHO	supernatant,	served	
as	 negaKve	 control	 of	 Adeno-DKK3-transfected	 CHO	 supernatant;	 DKK3,	 Adeno-DKK3-
transfected	 CHO	 supernatant.	 (B)	 FACS	 analysis	 was	 also	 performed	 on	 HUVECs	 with	
incubaKon	of	either	 recombinant	DKK3	or	overexpressed-CHO	supernatant	at	diﬀerent	
Kme	points	followed	by	staining	of	Annexin	V	anKbody	or	Propidium	Iodide.	In	each	dot	
plot,	 dots	 in	 Q3	 (lower	 right)	 indicates	 early	 apoptoKc	 cells;	 dots	 in	 Q2	 (upper	 right)	
indicates	necroKc	cells,	the	number	 in	each	grid	 indicates	cell	percentage	of	the	whole	
populaKon.	
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  Figure S9                                                                   Yu et al. 
Figure	S9.	DKK3-induced	HUVEC	migraEon	does	not	acEvate	β-catenin.	(A)	Western	bloing	
shows	 the	 expression	 of	 acKve	 and	 total	 β-catenin	 in	 HUVECs	 aZer	 treatment	with	 human	
DKK3	at	 indicated	Kme	points.	 Immunoﬂuorescence	staining	of	DKK3	on	HUVECs	with	either	
recombinant	DKK3	(B)	or	Adeno-DKK3-transfected	CHO	supernatant	(C)	sKmulaKon	to	idenKfy	
the	locaKon	of	DKK3	expression.		
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Figure	S10.	DKK3	has	no	eﬀect	on	RhoA	acEvaEon.	 	 (A)	
The	histograms	represent	the	eGFP	posiKve	HUVECs	aZer	
transfecKon	 with	 eGFP-labeled	 plasmids.	 (B)	 Pull	 down	
assay	 was	 performed	 to	 analyze	 acKvated	 RhoA	 (GTP-
RhoA)	 in	HUVECs	aZer	sKmulaKon	with	DKK3	at	diﬀerent	
Kme	points.		
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D 
Figure	S11.	DKK3	does	not	show	a	role	in	leukocytes	recruitment	and	macrophage	
migraEon.	(A)	The	peritoneal	cells	isolated	from	mice	that	3	days	aZer	injecKon	with	
saline,	 thioglycollate	 or	 mouse	 recombinant	 DKK3	 were	 counted	 under	 the	
microscope	and	 the	graph	 shows	 the	 cell	 number	per	milliliter	of	 	 each	group.	 (B)	
Flow	cytometry	analysis	shows	the	cell	components	 in	the	whole	cell	populaKon	of	
each	group.	 (C)	MigraKon	towards	mouse	recombinant	DKK3	was	evaluated	on	the	
peritoneal	macrophages	which	isolated	from	thiglycollate	sKmulaKon	in	vivo	by	using	
Transwell	 assay.	 (D)	 The	 quanKﬁcaKon	 of	 peritoneal	 macrophages	 migraKon	 was	
shown	in	mean	±	SEM.	ns,	no	signiﬁcance.	
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Figure	 S12.	 DKK3	 pretreatment	 did	 not	 inﬂuence	 DKK1-induced	
cytokine	 expression.	 HUVECs	 were	 pre-incubated	 with	 DKK3	 (50	
ng/ml)	 for	 1	 hour	 and	 then	 DKK1	 (50ng/ml)	 was	 added	 and	
incubated	for	12	hours.	The	cells	were	harvested	and	qPCR	for	IL-6	
and	 MCP-1	 were	 performed.	 Data	 are	 means±SEM	 of	 three	
experiments.	Note	 there	 is	 no	 signiﬁcant	 diﬀerence	 between	 two	
groups.	
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Figure S13. LRP5 and LRP6 antagonists did not block DKK3-
induced signalling and cell migration. Panel A, HUVECs were pre-
incubated with SOST/Sclerostin or Draxin (50 ng/ml) for 1 hour and then 
DKK3 (25 ng/ml) was added and incubated for 30 minutes. The cells 
were harvested and Western blots for JNK and Jun were performed. 
Panel B, HUVECs were pre-incubated with SOST/Sclerostin or Draxin 
(50 ng/ml) for 1 hour and then cell migration assay against DKK3 (25 
ng/ml) was performed. Note that LRP5 and LRP6 antagonists SOST/
Sclerostin or Draxin did not block the activity of DKK3 in endothelial 
migration.   
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Figure	 S14.	 SchemaEc	 representaEon	 of	 the	 mechanism	 by	 which	
DKK3	 induced	endothelial	cell	migraEon.	Soluble	DKK3	can	binds	 to	
Ror2/DVL	 on	 the	 surface	 of	 endothelial	 cells	 leading	 to	 Rac1	
acKvaKon,	which	in	turn	acKvates	JNK.	JNK	phosphorylates	c-Jun	that	
binds	 to	 the	 promoter	 region	 of	 genes,	 leading	 to	 cytoskeleton	
rearrangement.	The	overall	eﬀect	favorites	endothelial	cell	migraKon.	
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